GFA
8783
Chiome Bioscience
4583
Pixel
2743
Pluszero
5132
Silver Egg Technology
3961
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -16.65%64.4B | 9.88%78.83B | 43.63%80.37B | -3.42%286.66B | 19.53%81.7B | 38.27%77.26B | -15.74%71.75B | -36.00%55.95B | -17.91%296.8B | -32.34%68.35B |
Net profit before non-cash adjustment | -45.87%17.99B | -392.80%-86.09B | -117.24%-6.3B | 109.83%122.78B | 122.08%23.56B | -30.21%33.24B | -53.51%29.4B | -32.72%36.57B | -72.14%58.51B | -527.63%-106.72B |
Total adjustment of non-cash items | -18.68%45.36B | 284.21%169.1B | 66.97%96.94B | -40.74%191.83B | -80.62%33.98B | 37.01%55.78B | -8.30%44.01B | -2.76%58.06B | 77.68%323.72B | 130.20%175.31B |
-Depreciation and amortization | 0.39%45.26B | 5.89%45.98B | 7.33%45.55B | -5.55%175.35B | -7.74%44.4B | -4.79%45.08B | -8.48%43.42B | -0.69%42.44B | 11.33%185.66B | 7.24%48.13B |
-Reversal of impairment losses recognized in profit and loss | 6,400.00%260M | 2,379,360.00%118.97B | -62.41%209M | -99.53%605M | -99.97%40M | --4M | -99.04%5M | --556M | 272.85%128.45B | 276.10%127.93B |
-Share of associates | 3.86%-648M | -33.99%-548M | 26.69%-357M | -60.28%-1.98B | -159.39%-411M | -6.81%-674M | 38.59%-409M | 22.82%-487M | 46.07%-1.24B | 314.91%692M |
-Disposal profit | 685.26%1.23B | 34.29%1.03B | -28.15%845M | 167.52%4.15B | -63.01%2.06B | 101.15%156M | -29.32%764M | 61.98%1.18B | -242.25%-6.15B | 225.78%5.56B |
-Other non-cash items | -106.54%-733M | 1,508.33%3.67B | 252.58%50.7B | -19.39%13.71B | -73.07%-12.11B | 49.28%11.21B | 158.76%228M | -14.82%14.38B | 180.79%17.01B | -69.76%-7B |
Changes in working capital | 108.84%1.04B | -151.11%-4.18B | 73.44%-10.27B | 67.29%-27.95B | 10,166.25%24.16B | 63.76%-11.77B | 93.62%-1.67B | -45.18%-38.68B | -178.28%-85.44B | -163.74%-240M |
-Change in receivables | 84.02%-2.25B | 11.68%12.8B | 102.73%363M | -108.33%-8.71B | 900.28%7.19B | -67.54%-14.06B | 16.32%11.46B | -109.15%-13.3B | 77.13%-4.18B | 104.30%719M |
-Change in inventory | -176.90%-1.53B | 14.30%-4.6B | 90.23%-1.07B | 99.90%-88M | 2,538.96%14.22B | 106.82%1.98B | 83.68%-5.37B | 51.78%-10.92B | -72.91%-84.11B | 104.97%539M |
-Change in payables | 1,452.26%4.81B | -59.62%-12.38B | 33.80%-9.57B | -769.95%-19.15B | 283.11%2.74B | -93.81%310M | -156.08%-7.75B | -709.06%-14.45B | -92.11%2.86B | -105.45%-1.5B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 14.62%-4.49B | 8.29%-4.03B | -19.60%-4.74B | -107.56%-17.73B | -34.34%-4.12B | -137.16%-5.25B | -146.02%-4.39B | -168.81%-3.97B | -30.00%-8.54B | -85.03%-3.07B |
Interest received (cash flow from operating activities) | 0.49%3.73B | -3.00%3.81B | 12.06%3.41B | 24.48%14.19B | -38.06%3.52B | 111.10%3.71B | 26.06%3.93B | 256.21%3.04B | 71.11%11.4B | 167.44%5.68B |
Tax refund paid | 39.51%-11.44B | 67.14%-3.94B | 53.96%-11.48B | 14.47%-70.58B | -24.23%-14.73B | 7.08%-18.91B | 49.58%-12B | 5.91%-24.93B | -136.34%-82.51B | -16.26%-11.86B |
Other operating cash inflow (outflow) | 0 | 0 | 50.00%-1M | 0.00%-1M | 0 | 0 | 200.00%1M | -300.00%-2M | 50.00%-1M | 50.00%-1M |
Operating cash flow | -8.11%52.2B | 25.96%74.68B | 124.47%67.55B | -2.12%212.55B | 12.29%66.36B | 61.99%56.8B | -5.41%59.28B | -50.09%30.09B | -33.54%217.15B | -35.25%59.1B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -2.28%-51.76B | -18.10%-61.11B | -6.77%-53.73B | -1.97%-210.27B | 19.44%-57.59B | -47.73%-50.61B | 13.91%-51.75B | -24.71%-50.33B | -0.20%-206.2B | -51.79%-71.48B |
Net business purchase and sale | --0 | -83.32%183M | --21.94B | -88.51%1.79B | --0 | --689M | --1.1B | --0 | -68.65%15.55B | --0 |
Net investment product transactions | -21.17%6.66B | -40.99%6.07B | 93.70%9.26B | -31.92%32.76B | 31.57%9.24B | -62.05%8.45B | 19.84%10.29B | -53.37%4.78B | 55.58%48.13B | -57.06%7.03B |
Net changes in other investments | -522.92%-1.02B | -2.99%-688M | 89.34%-162M | -46.11%-4.07B | -23.63%-2.12B | 160.15%240M | -146.49%-668M | -280.95%-1.52B | -288.69%-2.79B | -175.05%-1.72B |
Investing cash flow | -11.85%-46.12B | -35.39%-55.55B | 51.78%-22.7B | -23.73%-179.79B | 23.74%-50.47B | -232.62%-41.23B | -13.21%-41.03B | -54.31%-47.07B | -17.39%-145.31B | -132.67%-66.17B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 33.51%26.64B | -24.84%-29.72B | -202.81%-47.26B | 456.77%9.3B | -58.29%-32.82B | 369.10%19.95B | -133.91%-23.81B | 62.28%45.97B | 100.77%1.67B | 83.32%-20.73B |
Net common stock issuance | 99.98%-4M | 93.78%-1.25B | 99.96%-5M | -14,526.02%-50.02B | -75.00%-7M | -462,800.00%-18.52B | -6,014.02%-20.05B | -190,633.33%-11.44B | 41.64%-342M | 33.33%-4M |
Cash dividends paid | 1.66%-22.29B | --0 | 4.45%-22.28B | 11.85%-45.98B | --0 | 2.77%-22.67B | --0 | 19.18%-23.32B | -68.02%-52.16B | --0 |
Cash dividends for minorities | -3.75%-581M | 56.53%-6.5B | 4.50%-1.32B | -30.53%-16.9B | 50.00%-14M | -1,300.00%-560M | -18.71%-14.95B | -381.47%-1.38B | -238.92%-12.95B | -100.00%-28M |
Net other fund-raising expenses | 66.67%130M | 134.76%228M | 121.92%877M | 69.41%-4.41B | 100.93%167M | -97.65%78M | -500.00%-656M | -21,157.89%-4B | -1,352.37%-14.42B | -29,006.45%-17.92B |
Financing cash flow | 117.93%3.89B | 37.38%-37.24B | -1,299.79%-69.98B | -38.12%-108.02B | 15.55%-32.67B | -37.55%-21.71B | -159.27%-59.47B | 833.71%5.83B | 69.00%-78.21B | 68.87%-38.69B |
Other cash adjustments within cash changes | --246M | ---223M | ---558M | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
Net cash flow | ||||||||||
Beginning cash position | -35.51%108.87B | -39.13%123.02B | -30.35%146.06B | 7.09%209.72B | -37.95%163.85B | -33.93%168.83B | -15.24%202.09B | 7.09%209.72B | -17.06%195.83B | 4.82%264.08B |
Current changes in cash | 266.50%10.22B | 55.52%-18.33B | -130.60%-25.69B | -1,081.18%-75.27B | 63.34%-16.77B | -189.19%-6.14B | -1,278.16%-41.21B | -138.40%-11.14B | 87.08%-6.37B | 25.50%-45.76B |
Effect of exchange rate changes | -559.66%-5.33B | -47.40%4.19B | -24.57%2.65B | -42.69%11.61B | 88.19%-1.02B | -29.65%1.16B | -41.60%7.96B | -74.17%3.51B | 124.11%20.26B | -261.71%-8.6B |
Cash adjustments other than cash changes | ---- | ---- | ---- | ---- | ---- | --0 | ---3M | 100.00%2M | --1M | --0 |
End cash Position | -30.57%113.76B | -35.51%108.87B | -39.13%123.02B | -30.35%146.06B | -30.35%146.06B | -37.95%163.85B | -33.93%168.83B | -15.24%202.09B | 7.09%209.72B | 7.09%209.72B |
Free cash flow | -111.94%-638M | 90.78%13.26B | 164.19%13.44B | 85.46%-985M | 159.69%7.66B | 134.05%5.34B | 229.28%6.95B | -206.63%-20.94B | -105.83%-6.78B | -129.49%-12.83B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |